CI
52
-7
CMS
58
-2
XRX
34
-3
UA
57
4
PX
73
-6
FTI
78
-3
CHRW
67
3
AES
41
2
FLS
76
-2
DOV
73
4
SLB
56
-3
MS
80
-3
UPS
50
9
EFX
41
-2
TXN
49
-6
SCHW
65
-2
NRG
50
-2
NWSA
71
-2
PSX
47
3
RCL
88
-2
CI
52
-7
CMS
58
-2
XRX
34
-3
UA
57
4
PX
73
-6
FTI
78
-3
CHRW
67
3
AES
41
2
FLS
76
-2
DOV
73
4
SLB
56
-3
MS
80
-3
UPS
50
9
EFX
41
-2
TXN
49
-6
SCHW
65
-2
NRG
50
-2
NWSA
71
-2
PSX
47
3
RCL
88
-2
Financhill
Back

Allogene Therapeutics Vs. Protalix BioTherapeutics Industry Stock Comparison

Sell
26

ALLO
Allogene Therapeutics

Last Price:
2.47
Seasonality Move:
-6.71%
Buy
64

PLX
Protalix BioTherapeutics

Last Price:
1.41
Seasonality Move:
72.04%
Sell
26
Allogene Therapeutics (ALLO) is a Sell

Is Allogene Therapeutics a Buy, Sell or Hold?

  • The current Allogene Therapeutics [ALLO] share price is $2.73. The Score for ALLO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ALLO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Protalix BioTherapeutics (PLX) is a Buy

Is Protalix BioTherapeutics a Buy, Sell or Hold?

  • The current Protalix BioTherapeutics [PLX] share price is $1.24. The Score for PLX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • PLX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ALLO Stock Price Chart

What is Allogene Therapeutics's stock price today?

  • The Allogene Therapeutics share price today is $2.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing selling pressure, which indicates risk of future bearish movement.

PLX Stock Price Chart

What is Protalix BioTherapeutics's stock price today?

  • The Protalix BioTherapeutics share price today is $1.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.

ALLO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 46.94 Sell
Chaikin Money Flow: -1489340 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.59 - 2.99) Sell
Bollinger Bands (100): (2.42 - 2.94) Buy

PLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 57.9 Buy
Chaikin Money Flow: -197064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.05 - 1.23) Buy
Bollinger Bands (100): (0.99 - 1.17) Buy

ALLO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.02 Sell
20-day SMA: 2.83 Sell
50-day SMA: 2.75 Sell
200-day SMA: 3.18 Sell
8-day EMA: 2.91 Sell
20-day EMA: 2.85 Sell
50-day EMA: 2.77 Sell
200-day EMA: 3.08 Sell

PLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.24 Buy
20-day SMA: 1.16 Buy
50-day SMA: 1.1 Buy
200-day SMA: 1.18 Buy
8-day EMA: 1.23 Buy
20-day EMA: 1.18 Buy
50-day EMA: 1.12 Buy
200-day EMA: 1.21 Buy

Allogene Therapeutics Earnings Growth & ALLO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.14 per share, and a decrease next year of $0.06 per share.

Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Allogene Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protalix BioTherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):